Liu H, Wang S, Wang J, Guo X, Song Y, Fu K
Signal Transduct Target Ther. 2025; 10(1):69.
PMID: 39966374
PMC: 11836267.
DOI: 10.1038/s41392-025-02141-x.
Gujaran T, Easwaran V, Sankhe R, Bakthavatchalam P, Dsouza H, Pai K
Oncol Res. 2025; 33(2):381-395.
PMID: 39866236
PMC: 11753998.
DOI: 10.32604/or.2024.049538.
Liang Z, Deng L, Zhou X, Zhang Z, Zhao W
Biomedicines. 2025; 13(1).
PMID: 39857793
PMC: 11760447.
DOI: 10.3390/biomedicines13010210.
Vaezi M, Nekoufar S, Robati A, Salimi V, Tavakoli-Yaraki M
Lipids Health Dis. 2024; 23(1):376.
PMID: 39543582
PMC: 11562866.
DOI: 10.1186/s12944-024-02368-7.
Zemer A, Samaei S, Yoel U, Biderman A, Pincu Y
Front Med (Lausanne). 2024; 11:1432717.
PMID: 39534224
PMC: 11554467.
DOI: 10.3389/fmed.2024.1432717.
Effect of short-term fasting on the cisplatin activity in human oral squamous cell carcinoma cell line HN5 and chemotherapy side effects.
Sheykhbahaei N, Tameemi A, Koopaie M
BMC Cancer. 2024; 24(1):989.
PMID: 39123141
PMC: 11316436.
DOI: 10.1186/s12885-024-12752-2.
A non-invasive screening method using for early detection of multiple cancer types: A prospective clinical study.
Hatakeyama H, Morishita M, Alshammari A, Ungkulpasvich U, Yamaguchi J, Hirotsu T
Biochem Biophys Rep. 2024; 39:101778.
PMID: 39104839
PMC: 11299558.
DOI: 10.1016/j.bbrep.2024.101778.
The Role of Metabolic Reprogramming in the Tumor Immune Microenvironment: Mechanisms and Opportunities for Immunotherapy in Hepatocellular Carcinoma.
Hu N, Li H, Tao C, Xiao T, Rong W
Int J Mol Sci. 2024; 25(11).
PMID: 38891772
PMC: 11171976.
DOI: 10.3390/ijms25115584.
An unexpected role for the ketogenic diet in triggering tumor metastasis by modulating BACH1-mediated transcription.
Su Z, Liu Y, Xia Z, Rustgi A, Gu W
Sci Adv. 2024; 10(23):eadm9481.
PMID: 38838145
PMC: 11152127.
DOI: 10.1126/sciadv.adm9481.
Targeting the gut microbiota to enhance the antitumor efficacy and attenuate the toxicity of CAR-T cell therapy: a new hope?.
Zhang P, Xie D
Front Immunol. 2024; 15:1362133.
PMID: 38558812
PMC: 10978602.
DOI: 10.3389/fimmu.2024.1362133.
Can a Low-Phosphate Diet for Chronic Kidney Disease Treat Cancer? An Interdisciplinary Literature Review.
Brown R, Bigelow P
Medicines (Basel). 2024; 11(2).
PMID: 38392693
PMC: 10890503.
DOI: 10.3390/medicines11020005.
Diet-driven microbiome changes and physical activity in cancer patients.
Ciernikova S, Sevcikova A, Stevurkova V, Mego M
Front Nutr. 2023; 10:1285516.
PMID: 38075222
PMC: 10704146.
DOI: 10.3389/fnut.2023.1285516.
Cancer Metabolism as a Therapeutic Target and Review of Interventions.
Halma M, Tuszynski J, Marik P
Nutrients. 2023; 15(19).
PMID: 37836529
PMC: 10574675.
DOI: 10.3390/nu15194245.
Ketogenic Diet and Multiple Health Outcomes: An Umbrella Review of Meta-Analysis.
Chen S, Su X, Feng Y, Li R, Liao M, Fan L
Nutrients. 2023; 15(19).
PMID: 37836444
PMC: 10574428.
DOI: 10.3390/nu15194161.
Cancer Vaccine Therapeutics: Limitations and Effectiveness-A Literature Review.
Kaczmarek M, Poznanska J, Fechner F, Michalska N, Paszkowska S, Napierala A
Cells. 2023; 12(17).
PMID: 37681891
PMC: 10486481.
DOI: 10.3390/cells12172159.
The Ketogenic Diet but not Hydroxycitric Acid Keeps Brain Mitochondria Quality Control and mtDNA Integrity Under Focal Stroke.
Gureev A, Silachev D, Sadovnikova I, Krutskikh E, Chernyshova E, Volodina D
Mol Neurobiol. 2023; 60(8):4288-4303.
PMID: 37074549
DOI: 10.1007/s12035-023-03325-8.
Diet-gut microbial interactions influence cancer immunotherapy.
Wang X, Geng S
Front Oncol. 2023; 13:1138362.
PMID: 37035188
PMC: 10081683.
DOI: 10.3389/fonc.2023.1138362.
Metabolic reprogramming in cancer: Mechanisms and therapeutics.
Nong S, Han X, Xiang Y, Qian Y, Wei Y, Zhang T
MedComm (2020). 2023; 4(2):e218.
PMID: 36994237
PMC: 10041388.
DOI: 10.1002/mco2.218.
Ketogenic Diet and Inflammation: Implications for Mood and Anxiety Disorders.
El Karkafi R, Gebara T, Salem M, Kamel J, El Khoury G, Zalal M
Adv Exp Med Biol. 2023; 1411:537-554.
PMID: 36949325
DOI: 10.1007/978-981-19-7376-5_23.
Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma.
Chen C, Wang Z, Ding Y, Qin Y
Front Immunol. 2023; 14:1133308.
PMID: 36845131
PMC: 9950271.
DOI: 10.3389/fimmu.2023.1133308.
